General Information of Drug (ID: DMY0UEQ)

Drug Name
VATALANIB Drug Info
Synonyms
Vatalanib; 212141-54-3; Vatalanib base; N-(4-chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine; PTK787; Pynasunate; CGP 79787; Vatalanib free base; PTK-787; Vatalanib (free base); Vatalinib; ZK-232934; CGP-79787; ZK222584; PTK/ZK; CHEMBL101253; N-(4-Chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine; UNII-5DX9U76296; CHEBI:90620; YCOYDOIWSSHVCK-UHFFFAOYSA-N; 1-(4-chloroanilino)-4-(4-pyridylmethyl)phthalazine; 5DX9U76296; NCGC00181350-01; 1-Phthalazinamine,N-(4-chlorophenyl)-4-(4-pyridinylmethyl)-; DSSTox_CID_26919
Cross-matching ID
PubChem CID
151194
ChEBI ID
CHEMBL90620
CAS Number
CAS 212141-54-3
TTD Drug ID
D0P6DJ

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Rheumatoid arthritis 2.28 0.00e+0 78/93 (83.87%) ICAM1;CCL20;IL6;...
Graft-versus-host disease 1.94 1.91e-2 32/42 (76.19%) IL6;IL1A;TNF;...
Cell adhesion molecules 1.93 1.27e-2 118/148 (79.73%) VTCN1;ICAM1;CLDN4;...
Allograft rejection 1.92 9.56e-3 32/38 (84.21%) TNF;HLA-B;HLA-DRB1;...
D-Glutamine and D-glutamate metabolism 1.87 1.15e-2 5/5 (100%) GLS;GLUD1;DGLUCY;...
TNF signaling pathway 1.81 2.07e-2 103/112 (91.96%) CASP10;ICAM1;CCL20;...
Synaptic vesicle cycle 1.79 2.59e-2 63/78 (80.77%) STX1A;SYT1;CLTA;...
Thiamine metabolism -1.77 4.63e-2 12/15 (80%) ALPL;AK5;AK1;...
Proteasome -1.87 2.46e-2 44/46 (95.65%) PSMD12;IFNG;PSMD14;...
Spliceosome -1.91 1.05e-2 101/150 (67.33%) HNRNPA3;RBM25;THOC1;...
Complement and coagulation cascades -1.95 1.05e-2 76/85 (89.41%) C3;PROS1;CFHR2;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 10uM 6H, 24H
Liver
Hepatocellular carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HuH-7 CVCL_0336 Homo sapiens 10uM 72H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 10uM 6H, 24H